Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (23)
COVID-19 (6)
Type
(
1 selected
)
Type
Guidance (1861)
NICE advice (323)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (761)
Apply filters
Showing 551 to 600 of 1861
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Endoscopic submucosal dissection of gastric lesions
IPG360
27 October 2010
27 October 2010
Endoscopic submucosal dissection of lower gastrointestinal lesions
IPG335
24 March 2010
24 March 2010
Endoscopic submucosal dissection of oesophageal dysplasia and neoplasia
IPG355
22 September 2010
22 September 2010
Endoscopic thoracic sympathectomy for primary facial blushing
IPG480
23 February 2014
23 February 2014
Endoscopic thoracic sympathectomy for primary hyperhidrosis of the upper limb
IPG487
27 May 2014
27 May 2014
Endoscopic transluminal pancreatic necrosectomy
IPG567
23 November 2016
23 November 2016
Endoscopic transsphenoidal pituitary adenoma resection
IPG32
17 December 2003
17 December 2003
Endoscopic ultrasound-guided biliary drainage for biliary obstruction
IPG761
19 April 2023
19 April 2023
Endoscopic ultrasound-guided gallbladder drainage for acute cholecystitis when surgery is not an option
IPG764
22 June 2023
22 June 2023
Endovascular atrial septostomy
IPG86
25 August 2004
25 August 2004
Endovascular closure of atrial septal defect
IPG96
27 October 2004
27 October 2004
Endovascular closure of patent ductus arteriosus
IPG97
27 October 2004
27 October 2004
Endovascular insertion of an intrasaccular wire-mesh blood-flow disruption device for intracranial aneurysms
IPG658
14 August 2019
14 August 2019
Endovascular stent insertion for intracranial atherosclerotic disease
IPG429
23 July 2012
23 July 2012
Endovascular stent–graft placement in thoracic aortic aneurysms and dissections
IPG127
22 June 2005
22 June 2005
Endovascular stent-grafting of popliteal aneurysms
IPG390
27 April 2011
27 April 2011
Endovenous laser treatment of the long saphenous vein
IPG52
24 March 2004
24 March 2004
Endovenous mechanochemical ablation for varicose veins
IPG557
25 May 2016
25 May 2016
ENDURALIFE powered CRT-D devices for treating heart failure
MTG33
17 March 2017
21 July 2021
Enfortumab vedotin for previously treated locally advanced or metastatic urothelial cancer (terminated appraisal)
TA797
15 June 2022
15 June 2022
Entecavir for the treatment of chronic hepatitis B
TA153
27 August 2008
27 August 2008
Entrectinib for treating NTRK fusion-positive solid tumours
TA644
12 August 2020
12 August 2020
Entrectinib for treating ROS1-positive advanced non-small-cell lung cancer
TA643
12 August 2020
12 August 2020
Enzalutamide for hormone-relapsed non-metastatic prostate cancer
TA580
15 May 2019
15 May 2019
Enzalutamide for metastatic hormone‑relapsed prostate cancer previously treated with a docetaxel‑containing regimen
TA316
23 July 2014
23 July 2014
Enzalutamide for treating hormone-sensitive metastatic prostate cancer
TA712
7 July 2021
7 July 2021
Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated
TA377
27 January 2016
27 January 2016
Epcoritamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatments
TA954
6 March 2024
6 March 2024
Epidermal radiotherapy using rhenium-188 paste for non-melanoma skin cancer
IPG784
2 April 2024
2 April 2024
Epiduroscopic lumbar discectomy through the sacral hiatus for sciatica
IPG570
14 December 2016
14 December 2016
Epilepsies in children, young people and adults
NG217
27 April 2022
27 April 2022
Epiretinal brachytherapy for wet age-related macular degeneration
IPG415
16 December 2011
16 December 2011
Episcissors-60 for mediolateral episiotomy
MTG47
11 February 2020
11 February 2020
Epithelial radiofrequency ablation for Barrett's oesophagus
IPG344
26 May 2010
26 May 2010
Eptinezumab for preventing migraine
TA871
1 March 2023
1 March 2023
Erenumab for preventing migraine
TA682
10 March 2021
10 March 2021
Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimen
TA515
28 March 2018
28 March 2018
Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens
TA423
21 December 2016
21 December 2016
Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy
TA374
16 December 2015
16 December 2015
Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancer
TA258
27 June 2012
27 June 2012
Erlotinib monotherapy for maintenance treatment of non-small-cell lung cancer
TA227
29 June 2011
29 June 2011
Ertugliflozin as monotherapy or with metformin for treating type 2 diabetes
TA572
27 March 2019
27 March 2019
Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetes
TA583
5 June 2019
5 June 2019
Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy
TA323
26 November 2014
26 November 2014
Esketamine for treating major depressive disorder in adults at imminent risk of suicide (terminated appraisal)
TA899
6 June 2023
6 June 2023
Esketamine nasal spray for treatment-resistant depression
TA854
14 December 2022
14 December 2022
Etanercept and efalizumab for the treatment of adults with psoriasis
TA103
26 July 2006
26 July 2006
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis
TA199
25 August 2010
25 August 2010
Etelcalcetide for treating secondary hyperparathyroidism
TA448
28 June 2017
28 June 2017
Etrasimod for treating moderately to severely active ulcerative colitis in people aged 16 and over
TA956
11 March 2024
11 March 2024
Previous page
1
…
10
11
Current page
12
13
14
…
38
Page
12
of
38
Next page
Results per page
10
25
50
All
Back to top